Plain-English translation of NCT06855368 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Researchers want to understand how the brain changes in the earliest stages of Alzheimer's disease and mild memory loss. They will study how different areas of the brain communicate with each other using special brain scans and memory tests. This information could help doctors catch memory problems much earlier, when new treatments might work better.
Alzheimer's disease damages the brain long before people notice memory problems. By the time symptoms appear, it may be too late for some treatments to help. This trial is looking for early warning signs in how the brain works so doctors can step in sooner and develop better medicines.
You likely qualify if…
You likely don't qualify if…
You would visit the research center for brain imaging scans and memory and thinking tests. The study compares three groups: people with mild Alzheimer's, people with mild memory problems, and healthy volunteers without memory issues. Your specific visits and timeline would depend on which group you join, but researchers will use the scans and tests to look for patterns that show early brain changes.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Italy
Enrollment target
~300 participants
Started
May 2023
Primary completion
May 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lucia Gatta, PhD
IRCCS San Raffaele Roma
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.